Graded review
VO2 Max and Longevity: The Strongest Fitness Predictor of Lifespan
Cardiorespiratory fitness is one of the best-validated predictors of mortality — low fitness carries risk on par with smoking, and it's trainable.
Evidence scorecard
- What VO2 max isMixed / emerging
- Why it predicts mortality so wellMixed / emerging
- The honest caveatsThin / contested
- The genuinely good news: it's trainableMixed / emerging
- How to actually measure yoursMixed / emerging
- Where this fits in evidence-based longevityWell-supported
- The bottom lineMixed / emerging
Of all the numbers people chase in the name of living longer, VO2 max has the strongest claim to actually matter. It is the single best-validated fitness predictor of how long you'll live — not a supplement, not a clock, not a clinic protocol, but a measure of how much oxygen your body can use at maximal effort. The evidence behind it is unusually deep and consistent: large prospective cohorts, a formal American Heart Association statement, and a clean dose-response gradient where more fitness means lower death rates. Crucially, unlike your age or your genes, it is something you can change. Here is what the science actually shows, graded honestly.
What VO2 max is
VO2 max (maximal oxygen uptake) is the highest rate at which your body can take in, transport, and use oxygen during all-out exercise, expressed in milliliters of oxygen per kilogram of body weight per minute (mL/kg/min). It is the gold-standard measure of cardiorespiratory fitness (CRF) — the integrated capacity of your lungs, heart, blood, and muscles to deliver and consume oxygen. A higher number means a more capable engine.
The textbook measurement is a graded exercise test on a treadmill or bike with a mask analyzing your expired air. In research and clinical practice, fitness is also commonly estimated from how long and how hard someone can sustain a treadmill protocol, expressed in metabolic equivalents (METs), where 1 MET is resting metabolism and higher peak METs mean higher fitness. Wearables now estimate VO2 max from heart-rate-to-pace relationships; those estimates are useful for tracking trends but are not as accurate as a lab test.
Why it predicts mortality so well
This is where VO2 max separates itself from almost every other longevity marker: the evidence is both large and old, which is exactly what you want.
The landmark modern study analyzed 122,007 adults who underwent treadmill exercise testing and were followed for a median of 8.4 years. The relationship between fitness and survival was strikingly graded: the least-fit participants had dramatically higher all-cause mortality, and there was no observed upper limit to the benefit — the very fittest (elite performers) had the lowest mortality of all1. The authors framed the size of the effect bluntly: the risk associated with the lowest fitness was comparable to or greater than traditional clinical risk factors such as smoking, diabetes, and hypertension1.
Strength of evidence
- ALow fitness predicts higher mortalityStrong evidence
122,007-adult cohort + 2009 meta-analysis + 1989 cohort; risk on par with smoking/diabetes.
- AVO2 max is improvable with trainingStrong evidence
Interval and continuous aerobic training both raise CRF in middle-aged and older adults.
- BRaising YOUR VO2 max extends YOUR lifeModerate evidence
Strong association, but observational — no randomized lifespan trial; causation not proven.
That finding sits on a deep foundation. In a classic study of men referred for exercise testing, peak exercise capacity was a more powerful predictor of death than established cardiovascular risk factors, and each 1-MET increase in capacity conferred roughly a 12% improvement in survival2. A 2009 meta-analysis pooling healthy men and women confirmed the gradient across populations: higher CRF predicted substantially lower all-cause mortality and fewer cardiovascular events, with low fitness carrying a markedly elevated risk3. And the foundational 1989 cohort from the Aerobics Center showed the same pattern decades earlier — higher physical fitness predicted lower all-cause mortality in both men and women, with the steepest benefit gained moving from the least-fit group to merely moderately fit4.
The convergence of these studies — across eras, populations, and methods — is why the American Heart Association issued a 2016 scientific statement arguing that CRF should be treated as a clinical vital sign, measured and tracked like blood pressure, because it adds prognostic information beyond standard risk factors5. Very few longevity interventions earn that kind of institutional backing. (For how this fits the broader, honestly-graded landscape, see our pillar on the evidence behind longevity medicine.)
The honest caveats
None of this means VO2 max is a magic number, and honest framing matters here. First, almost all of this evidence is observational — these are associations, not randomized proof that raising your VO2 max causes you to live longer. People who are fitter differ in many ways (they tend to be leaner, less likely to smoke, more affluent, healthier at baseline), and statistical adjustment is imperfect. The biological case is strong and the dose-response is clean, but the formal causal claim — "improve your fitness, extend your life" — has not been proven by a randomized lifespan trial, because such a trial is essentially impossible to run.
Second, this is a healthspan and mortality-risk marker, not a guarantee of extra years for any one person. A high VO2 max strongly tilts the population odds in your favor; it does not exempt an individual from cancer, accidents, or bad genetics.
Third, the number is relative to your age and sex. A VO2 max of 35 mL/kg/min is poor for a 25-year-old man but excellent for a 70-year-old woman. Reference standards from the large FRIEND registry of cardiopulmonary exercise tests exist precisely so that a measured value can be placed into an age- and sex-specific percentile rather than judged against a single threshold6. What matters for risk is where you fall in your own demographic band, and which direction you're trending.
The genuinely good news: it's trainable
Here is what elevates VO2 max from interesting to actionable. Unlike a DNA-methylation clock or your chronological age, cardiorespiratory fitness responds to training at essentially any age — and the biggest risk reduction in every cohort comes from leaving the bottom fitness category, which is the most achievable improvement there is4.
Both moderate continuous aerobic exercise (the classic "Zone 2" steady-state work) and higher-intensity interval training raise VO2 max. A 2021 systematic review and meta-analysis in middle-aged and older adults found that interval training and moderate-intensity continuous training both improved cardiorespiratory fitness, with interval training producing somewhat larger VO2 max gains in this population7. The practical synthesis most exercise physiologists land on is a base of frequent easy-to-moderate aerobic work to build volume, plus a smaller dose of harder intervals to push the ceiling — but the dominant message from the mortality data is simpler: any move up from the least-fit category is where the largest survival benefit lives14.
The dose-response chain
Aerobic training
Zone 2 base + intervals
Higher VO2 max
Move up your age/sex percentile
Lower mortality risk
Biggest gain: leaving the least-fit band (association)
VO2 max also belongs to the same family of cheap, functional measures that predict survival — grip strength, gait speed, and the chair-stand among them — that a 2010 BMJ meta-analysis tied to mortality across community-dwelling adults8. It is the cardiovascular member of that family, and arguably the best-studied. (Its muscular counterpart is covered in our look at grip strength as a longevity biomarker, and the floor-mobility version in the sitting-rising test and longevity.)
How to actually measure yours
You have three tiers of options. A laboratory or clinical cardiopulmonary exercise test (CPET) with a mask is the accurate gold standard and the one used in the research above; it is also the most expensive and least convenient. A submaximal field test (a timed run, a step test, or a treadmill protocol scored in METs) gives a reasonable estimate. And a wearable that estimates VO2 max from heart rate and pace is the least accurate but the easiest to repeat — best used to watch your own trend over months rather than to pin down an exact value.
For most people the useful workflow is: get one decent baseline (lab if you can, a validated field test if not), place it in an age- and sex-specific percentile using FRIEND-style reference standards6, and then train to move up a band — re-testing every few months. If you're building a broader assessment, this pairs naturally with the lab side of the picture in our guide to longevity biomarker panels.
Where this fits in evidence-based longevity
Among the things marketed under the longevity banner, cardiorespiratory fitness stands out for having the rare combination the others lack: a huge, consistent, decades-deep evidence base; an effect size on par with major clinical risk factors; institutional endorsement as a vital sign; and — best of all — genuine modifiability at any age. It earns an honest high grade not because of hype but because the data keep saying the same thing. If you want to see how the clinics and programs that build structured fitness and assessment into longevity care actually compare on evidence, oversight, and price, we grade the field in our best longevity clinics hub.
The bottom line
VO2 max is, on the current evidence, the strongest fitness-based predictor of longevity we have. Low cardiorespiratory fitness carries mortality risk comparable to smoking or diabetes, and the relationship is graded with no clear ceiling — fitter is better, all the way up. The honest caveat is that the evidence is observational, so it proves strong association rather than guaranteed causation, and your number must be read against your own age and sex. But the practical takeaway is unusually clean: this is a high-impact marker you can actually move, the biggest gains come from leaving the least-fit group, and a mix of easy aerobic volume and harder intervals is how you do it.
Frequently asked questions
Is VO2 max really the best predictor of longevity?
Among fitness measures, it has the strongest and most consistent evidence. In a 122,007-adult study, low cardiorespiratory fitness carried mortality risk comparable to or greater than smoking, diabetes, and hypertension, with a graded benefit and no observed upper limit. The American Heart Association recommends treating fitness as a clinical vital sign. The main caveat: this evidence is observational, so it shows strong association rather than proven causation.
What's a good VO2 max for my age?
It depends heavily on age and sex — a value that's poor for a 25-year-old can be excellent for a 70-year-old. Rather than chase a single number, place your measured VO2 max into an age- and sex-specific percentile using reference standards like the FRIEND registry, and focus on which direction you're trending.
Can you actually improve your VO2 max?
Yes, at essentially any age — that's what makes it actionable. A 2021 meta-analysis in middle-aged and older adults found both interval training and moderate-intensity continuous aerobic exercise raised VO2 max. The largest mortality benefit in every cohort comes from leaving the least-fit category, which is also the most achievable improvement.
How do you measure VO2 max accurately?
The gold standard is a lab cardiopulmonary exercise test (CPET) with a mask analyzing your breath. Submaximal field tests and treadmill protocols scored in METs give reasonable estimates. Wearables estimate it from heart rate and pace — least accurate, but easy to repeat for tracking your trend over months.
References
- Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing.. JAMA Network Open. https://pubmed.ncbi.nlm.nih.gov/30646252/
- Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002). Exercise capacity and mortality among men referred for exercise testing.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/11893790/
- Kodama S, Saito K, Tanaka S, et al. (2009). Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.. JAMA. https://pubmed.ncbi.nlm.nih.gov/19454641/
- Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW (1989). Physical fitness and all-cause mortality. A prospective study of healthy men and women.. JAMA. https://pubmed.ncbi.nlm.nih.gov/2795824/
- Ross R, Blair SN, Arena R, et al. (American Heart Association) (2016). Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association.. Circulation. https://pubmed.ncbi.nlm.nih.gov/27881567/
- Kaminsky LA, Arena R, Myers J, et al. (2022). Updated Reference Standards for Cardiorespiratory Fitness Measured with Cardiopulmonary Exercise Testing: Data from the Fitness Registry and the Importance of Exercise National Database (FRIEND).. Mayo Clinic Proceedings. https://pubmed.ncbi.nlm.nih.gov/34809986/
- Poon ET, Little JP, Sit CH, Wong SH (2021). Interval training versus moderate-intensity continuous training for cardiorespiratory fitness improvements in middle-aged and older adults: a systematic review and meta-analysis.. Journal of Sports Sciences. https://pubmed.ncbi.nlm.nih.gov/33825615/
- Cooper R, Kuh D, Hardy R; Mortality Review Group (2010). Objectively measured physical capability levels and mortality: systematic review and meta-analysis.. BMJ. https://pubmed.ncbi.nlm.nih.gov/20829298/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Longevity Medicine: What's Proven vs Hyped
An honest, evidence-graded tour of the longevity toolkit — what has human outcome RCTs versus what is animal or mechanistic-only.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
ReadRapamycin & Metformin for Longevity: The Evidence
Strong animal data, a glaring human RCT gap. What the PEARL pilot, the TAME rationale, and metformin's observational signal really show.
ReadAre Longevity Clinics Worth It?
DTC and IV longevity clinics sit on the weakest evidence in the field. What a critical review found, and how to vet a provider before paying.
ReadRapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadLongevity Clinics vs Lab Memberships vs Rx Telehealth: What Each Delivers
The longevity market splits into four bands: concierge clinics, membership programs, DTC labs, single-product Rx. What each delivers, and who it's for.
ReadBiological Age Tests: Do Epigenetic Clocks Actually Work?
Epigenetic clocks (Horvath, GrimAge, DunedinPACE) predict aging well in populations — but are noisy and unproven for individuals. An honest evidence review.
ReadNAD+ for Longevity: What the Trials Actually Show
NR and NMN reliably raise NAD+ in humans, but the trials mostly fail to show clinical or longevity outcomes. An honest review of the hype versus the data.
ReadWhat Do Longevity Biomarker Panels Actually Test?
Longevity panels mix genuinely useful, outcome-validated markers (ApoB, HbA1c, hs-CRP) with vanity numbers. An honest, evidence-graded breakdown.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadPeptides for Longevity: What's Real and What's Marketing
Most longevity peptides are sold on mechanism and anecdote, not human outcomes. An honest, citation-backed review of what the evidence actually supports.
ReadMetformin for Longevity: The TAME Trial Evidence
Metformin's anti-aging case is mechanistic and observational — no completed RCT proves it. Why the TAME trial exists, and the exercise caveat.
ReadConcierge vs Membership Longevity: What You Actually Get
Concierge clinics ($8k–$25k/yr) sell diagnostics; membership programs ($99–$300/mo) sell ongoing treatment. What each delivers, and where the money goes.
ReadHow We Grade Longevity Providers: Our Methodology
The five-axis rubric behind our longevity provider rankings: oversight, evidence honesty, transparency, price, and conflicts of interest.
ReadBest Longevity Supplements, Rated by Evidence (2026)
We grade the popular longevity supplements — NMN, NR, spermidine, resveratrol, CoQ10, omega-3, vitamin D, fisetin, GlyNAC — on human evidence, not hype.
ReadWhat Is a Longevity Doctor (and Do You Need One)?
A longevity doctor blends preventive medicine, biomarker testing, and lifestyle coaching. What they really do, credentials to check, and who needs one.
ReadSpermidine for Longevity: What the Evidence Shows
Spermidine induces autophagy and dietary intake tracks with lower mortality — but the best human trial was negative. An honest, evidence-graded review.
ReadThe Sitting-Rising Test & Longevity: What the Evidence Actually Shows
The sitting-rising and sit-to-stand tests predict mortality in research — but they're markers of strength, balance, and flexibility, not a verdict.
ReadHow Much Does a Longevity Clinic Cost?
Longevity care runs from ~$200/yr lab memberships to $20k+ concierge programs. A 2026 price-band guide to what each tier buys — and what's worth paying for.
ReadFree Biological-Age Tests & Calculators: Do They Actually Work?
Free biological-age calculators range from validated (PhenoAge from a basic blood panel) to entertainment. An honest guide to what's worth your time.
ReadTaurine for Longevity: Does the 2023 Science Study Hold Up?
A 2023 Science paper called taurine deficiency a driver of aging. A 2025 Science follow-up questioned its core premise. An honest, evidence-graded review.
ReadUrolithin A (Mitopure): Mitochondrial Hype or Real?
Urolithin A (Mitopure) has the cleanest human-trial record of any mitochondrial supplement — modest muscle gains in RCTs. But healthspan isn't lifespan.
ReadFisetin as a Senolytic: What "Hit-and-Run" Dosing Shows
Fisetin was the standout senolytic flavonoid in mouse screens and extended lifespan ~10%. In humans, the longevity data are essentially zero. An honest review.
ReadGlyNAC (Glycine + NAC) for Aging: What the Baylor Trials Actually Show
Baylor RCTs report GlyNAC corrects glutathione deficiency and several aging hallmarks in older adults. But the trials are small and the headlines overstate it.
ReadAlpha-Ketoglutarate (Rejuvant/AKG): Does the "8 Years Younger" Claim Hold Up?
The viral "8 years younger" AKG result came from a 42-person study with no placebo group and an unvalidated aging clock. An honest evidence review.
ReadDasatinib + Quercetin: How Far Along Is the Flagship Senolytic?
Dasatinib + quercetin is the first-in-human senolytic — with small IPF and kidney signals. But it's a chemo drug plus a flavonoid, with no longevity RCT yet.
ReadTruDiagnostic TruAge Review: Is the $229 Epigenetic Clock Worth It?
TruDiagnostic's TruAge uses the well-validated DunedinPACE clock — but no test proves the score predicts YOUR outcomes. An honest, evidence-graded review.
ReadFunction Health Review: Are 100+ Biomarkers Worth $499/yr?
Function Health's 100+ lab membership surfaces real outcome-validated markers — but roughly half are basic labs, and it tests without treating. Honest review.
ReadBryan Johnson's Blueprint Review: Evidence vs N-of-1 Hype
Bryan Johnson's Blueprint is a single-subject experiment with no control group — and roughly 90% of its likely benefit is replicable diet, sleep, and exercise.
ReadGrip Strength as a Longevity Biomarker: What the Evidence Shows
In the 140,000-person PURE study, grip strength outpredicted systolic blood pressure for mortality. A genuinely strong, free, at-home biomarker.
ReadFasting-Mimicking Diet (ProLon) Review: Does the Evidence Hold Up?
ProLon's 5-day fasting-mimicking diet has real human trials behind it — but most are tied to its inventor's company. An honest, graded look.
ReadHyperbaric Oxygen for Aging: Does the Telomere Claim Hold Up?
One small Israeli trial reported HBOT lengthened telomeres 38% and cut senescent cells. It's striking, unreplicated, and expensive. An honest, graded review.
ReadCreatine for Aging: The Cheapest Evidence-Backed Supplement?
Creatine has the strongest human evidence of any longevity supplement — for healthspan, not lifespan. With resistance training it adds muscle and strength.
ReadThe Hallmarks of Aging, Explained (and Why They Matter)
The hallmarks of aging are the cellular processes that drive getting old. A plain-English guide to the 2013 and 2023 framework — and why each one gets targeted.
ReadSulforaphane for Longevity: Promising Biology, Preclinical Proof
Sulforaphane from broccoli extends lifespan in worms and activates Nrf2 — but the human longevity evidence is preclinical. An honest, evidence-graded review.
ReadGlycine for Longevity: The Other Half of GlyNAC
Glycine alone extended mouse lifespan ~6% in the ITP. But the dramatic 'reverses aging' results belong to the GlyNAC combo, not solo glycine. An honest review.
Read